Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Texas A&M University3,000 enrolled

Overview

This program collects genetic and health information to help doctors choose the right medications for patients.

This study wants to understand how genes can affect how the body responds to medicines. This information will help us determine whether changing your medicine can make you healthier and improve your life. We will study your medical history for the last year and the next five years after you join the study. study goals include: * Enrolling patients who take multiple medications or have harmful side effects from their medications. * Keeping all medical information and genetic samples from patients in one place. * Helping doctors make better decisions about which medicines to prescribe. * Influencing insurance companies and the government to help pay for this kind of medical care for people who need to change their medicine to stay healthy.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Diabetes Cholesterol Cancer Blood Pressure Disorders Heart Disease Respiratory Ilness COPD Adverse Drug Reaction (ADR)Poly Pharmacy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The study will invite patients who are eligible for PGX workup/PGX care to participate, provided they meet the following criteria: Use of five or more medications, including over the counter drugs, supplements, natural products, cannabis products, or other recreational drugs, or * Individuals taking blood pressure or depression medications, even if less than five medications. * Ability to understand and give consent. * Able to consent to donate blood and/or urine samples and buccal swabs. * Able to answer detailed questionnaires, including quarterly questionnaires about ADRs, cognitive testing such as serial mini-mental status exams, and or quality of life questions. * Able to understand that their health record and changes in health status will be followed for a five-year period and shared in deidentified form with the research community. * All genders. * Any age over 18 years. Exclusion Criteria: * Individuals admitted to hospice. * Declines to participate or interact with staff/share their medical status. * A diagnosis of Alzheimer's disease or related dementias in a medical record as this indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning., * Individuals who are unable or unwilling to provide consent. * Unable to verbally communicate and comprehend English language

Locations (1)

Texas A&M Family Care

Bryan, Texas, United States

RECRUITING

Outcomes

Primary Outcomes

Frequency and nature of ADRs on the Naranjo Scale

Patients will be referred to the Texas A\&M Interprofessional Pharmacogenomics Clinic (IPGx) by their primary care physicians. A physician or ambulatory pharmacist in the IPGx clinic or Family Care Clinic will obtain a complete medical history, physical examination, and validate the patient's current concomitant medication list at the IPGx during the office visit. Patient medical information would be input into the CSN, which functions as a computable EHR medical record analysis, evaluation of polypharmacy status, and monitoring of Adverse Drug Reactions using the Naranjo Scale questionnaire will be conducted for the duration of the study.

Time frame: 5 years

Secondary Outcomes

Serum/plasma drug concentrations

Patients will be referred to the Texas A\&M Interprofessional Pharmacogenomics Clinic (IPGx) by their primary care physicians for an evaluation of pharmacokinetic and pharmacodynamic (PK/PD) assessments. For drug level measurement, urine samples will be collected using provided kits and shipped to the contracted laboratory via FedEx in biosafety shipping containers.

Time frame: 5 years

Central Contacts

Kenneth S Ramos, MD, PhD

CONTACT

(713) 677-7440 kramos@tamu.edu

Rick Silva, PhD

CONTACT

ricksilva@tamu.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.